Zoster Immunoglobulin-VF (CSL) is a medicine containing the active ingredient(s) varicella-zoster virus immunoglobulin. On this page you will find out more about Zoster Immunoglobulin-VF (CSL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: varicella-zoster virus immunoglobulin
Information for medicine and pack size:
Zoster Immunoglobulin-VF (CSL) 200 units injection solution, 1 vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS AS AT 8 AUGUST 2002 : Zoster Immunoglobulin is indicated for prophylaxis against varicella in patients who meet all four of the criteria listed below: 1. One of the following underlying illnesses or conditions: a. Neoplastic disease (leukaemia or lymphoma); b. Congenital or acquired immunodeficiency; c. Immunosuppressive therapy with steroids or antimetabolites. 2. One of the following types of exposure to chickenpox or shingles patients: a. Household contact; b. Playmate contact (>1 hour play indoors); c. Hospital contact (in same 2 to 4 bedroom or adjacent beds in a large ward); d. Newborn contact (newborn of mother who had onset of chickenpox <5 days before delivery or within 48 hours after delivery); e. Premature infant (>= 28 weeks gestation) whose mother lacks a prior history of chickenpox; f. Premature infant (< 28 weeks gestation or <= 1000g) regardless of maternal history. 3. Negative or unknown history of chickenpox. 4. If Zoster Immunoglobulin can be administered within 96 hours after exposure. Zoster Immunoglobulin, Normal Immunoglobulin (immunoglobulin for intramuscular use) or plasma are of no value in the treatment of established varicella or zoster infection. High levels of circulating antibody do not prevent dissemination of infection. Zoster Immunoglobulin is not indicated for prophylactic use in immunodeficient children or adults when there is a history of varicella, unless the patient's immunosuppressed status is that which is associated with bone marrow transplantation.
Table of characteristics
|Visual appearance||Clear to opalescent, colourless, solution|
|Dosage Form||Injection, solution|
|Route of administration||Intramuscular|
200IU x 1: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Refrigerate,Protect from Light,Do not Freeze|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.